You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) PROPYLENE GLYCOL MONOLAURATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing PROPYLENE GLYCOL MONOLAURATE excipient, and estimated key patent expiration / generic entry dates

Company Tradename Ingredient NDC Excipient Potential Generic Entry
Trifluent Pharma LLC UNDECATREX testosterone undecanoate 73352-105 PROPYLENE GLYCOL MONOLAURATE 2030-12-31
Marius Pharmaceuticals KYZATREX testosterone undecanoate 80603-101 PROPYLENE GLYCOL MONOLAURATE 2030-12-31
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Market Dynamics and Financial Trajectory of Propylene Glycol Monolaurate

Last updated: February 23, 2026

What Is Propylene Glycol Monolaurate?

Propylene Glycol Monolaurate (PGML) is an esterified compound derived from propylene glycol and lauric acid. It functions primarily as an emulsifier, stabilizer, and thickening agent within food, cosmetic, and pharmaceutical industries. PGML is recognized for its solubility in oils and fats and its ability to enhance product stability and texture.

Market Size and Growth Drivers

Global Market Valuation

The global excipient market, valued at approximately USD 11.8 billion in 2022, encompasses PGML as a niche specialty chemical. Specific market size data for PGML remains limited, owing to its relatively low volume, specialty nature, and the fragmented supplier landscape.

Compound Annual Growth Rate (CAGR)

The overall demand for emulsifiers and stabilizers in pharmaceuticals is projected to grow at a CAGR of 5.6% from 2023 to 2028, driven by increased formulations in topical, oral, and injectable drugs. PGML's market share within this segment is expected to increase modestly, supported by:

  • Rising adoption in drug delivery systems
  • Expansion in cosmetic and skincare sectors
  • Growing demand for natural and plant-based ingredients

Key Demand Sectors

Sector Approximate Market Share Growth Drivers
Pharmaceuticals 45% Improved drug stability and bioavailability
Cosmetics & Personal Care 35% Emulsifier properties, consumer preference
Food Industry 15% Claims of safety and functional benefits
Other (e.g., animal feed, etc.) 5% Niche applications

Market Dynamics

Supply Chain and Production

Major manufacturers of PGML include multinational chemical companies and regional specialty chemical producers. Raw material availability, particularly lauric acid sourced from coconut or palm kernel oil, influences supply chain stability. Fluctuations in raw material prices directly impact PGML costs.

Regulatory Environment

The U.S. Food and Drug Administration (FDA), European Food Safety Authority (EFSA), and similar agencies globally have approved PGML for use in food, pharmaceuticals, and cosmetics, under specified purity standards. Regulatory approvals streamline market access but also impose compliance costs.

Competitive Landscape

Major players include Archer Daniels Midland, Emultech, and Clariant. Market entry barriers involve technical expertise, regulatory approval, and significant R&D investments.

Trends Impacting Growth

  • Shift toward natural and biodegradable excipients reduces reliance on synthetic alternatives.
  • Increasing R&D activities exploring PGML in drug delivery formats.
  • Rising consumer demand for clean-label products influences formulation choices.

Financial Trajectory and Investment Outlook

Revenue Projections

While precise PGML-specific revenue data is scarce, the associated emulsifier segment in the pharmaceutical excipient market is expected to grow to USD 950 million by 2028 (from USD 622 million in 2023), reflecting broader industry trends.

Cost Structure

The cost to produce PGML depends on:

  • Raw material prices (lauric acid, propylene glycol)
  • Manufacturing scale and efficiency
  • Regulatory compliance expenses

Typical manufacturing margins are estimated at 15-20%, though this varies with raw material volatility and automation levels.

Investment Attractiveness

Investments in PGML production capacity are driven by:

  • Growing demand in emerging markets
  • Expansion of pharmaceutical formulations
  • R&D pipelines for novel delivery systems involving PGML

Capex for new production lines ranges between USD 10-50 million, with breakeven periods of 3-5 years depending on scale and market penetration.

Challenges and Risks

  • Raw material price volatility
  • Stringent regulatory requirements
  • Competition from alternative emulsifiers (e.g., polyglyceryl esters)
  • Market saturation in mature regions

Summary of Market Factors

Factor Impact
Raw material price fluctuations Cost increases may reduce margins
Regulatory standards Can delay product launch or increase compliance costs
Consumer trends favoring natural ingredients Shift toward plant-derived emulsifiers influences PGML value
Technological innovation New formulations may expand PGML applications

Key Takeaways

  • PGML is a specialized excipient with growth tied to pharmaceutical emulsification, cosmetic stabilization, and niche applications.
  • Market growth aligns with the broader emulsifier and excipient sector, forecasted at a 5.6% CAGR through 2028.
  • Supply chain stability heavily relies on raw material prices, and regulatory landscapes influence market access.
  • Investment in PGML production benefits from expanding pharmaceutical R&D and natural ingredient trends but faces challenges from raw material costs and competitive substitutes.

5 FAQs

Q1: What are the main industries driving demand for PGML?
Pharmaceuticals and cosmetics are primary drivers, utilizing PGML for its emulsification and stabilization properties.

Q2: How do raw material prices affect PGML market stability?
Fluctuations in lauric acid and propylene glycol prices directly impact production costs and profit margins.

Q3: What regulatory approvals are necessary for PGML use?
Approval depends on jurisdiction; FDA and EFSA certifications are common for food and pharma applications, ensuring purity and safety standards.

Q4: Is the market for PGML saturated?
Market growth is moderate, with opportunities in niche and emerging applications, but competition from alternative emulsifiers persists.

Q5: What are the prospects for new entrants in PGML production?
High capital requirements, technical expertise, and regulatory hurdles limit rapid market entry, favoring established chemical producers.


References

  1. Allied Market Research. (2022). Emulsifiers Market by Type, Source, and Application.
  2. MarketsandMarkets. (2023). Pharmaceutical Excipients Market by Type, Application, and Region.
  3. U.S. Food and Drug Administration. (2021). Guidance for Industry: Emulsifiers in Drug Products.
  4. European Food Safety Authority. (2022). Scientific Opinion on the Safety of Food Additives and Emulsifiers.
  5. Chemical Market Analytics. (2023). Raw Materials Price Trends and Impact Analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.